Saw guys talking about it on the Facebook page, but can't see the context or message anywhere. If true it would be a significant signal. Will keep poking around, see if there's any truth to it.
Is it true Mullis said this yesterday in response to an email about a takeover or similar?
To be fair, it does get the chat hot. Visibility might help snag some new interest!
@Safy
65% margin NCYT said recently
@Jimboooo
That's right on the money. Investors have been burned on AIM so many times over the years.
At some point they see they're holding a 50p position on a stock that was worth 3p a few months ago and they get worried about it being a pump n dump job.
I get that and respect it, but ultimately it's how great companies start too. Take 20 of these Covid stocks and one or two will genuinely make the cash and grow. Rest will take investors money, pay a bunch of staff and bonuses then slowly die off.
I played in a bunch of these, and left NCYT around the 400s for the same reason. It was always going to be a case of finding the stock that actually made stupid amounts of cash and would grow month on month for the rest of the year AND show the nous to invest in a future away from Covid.
I think this is it. I'm not a loyalist, but I can't see anything else listed on AIM close to NCYT right now.
Companies on AIM do placings for less than 1 million pounds.
Think about that.
Hooking up with dodgy nomad/brokers to pull off sub 1 mill placings to get to move the business forward.
NCYT's on track, debt free, to pull in 10's of millions a month. A month.
It's a dream for these guys. They're a decade ahead of where they imagined and all the clever ideas they always wanted to get into can now get realised. Ride the train for 2020 at least, see where it goes. Try not to let the hedge fund and MM guys get you too down in the meantime. They're here to make cash too. They need to buy low sell high just like us. Difference is they're able to move the market to make that happen while we need to be patient to get our chance.
@Alan
From the lowest close on 15th June it's now up 17% after a rough couple of days. It's hit highs of 305p on 6th July, and 310p on 13th July.
You're asking for a lot! I'm not a huge fan of charts for AIM stocks, but the basics always serve you well. This is recovering without news during a period where buyers are scared of Covid stocks. You can see the Covid stock index on Vox, the market is running scared. NCYT is up trending strongly though.
Growth now is real growth, not some theoretical billion + share price calculation. Show sales and sustainable growth over the next 12+ months and you'll get the markets cash. Give NCYT a little more time to get the news out on sales and developments and this is the winner. Everything else is short term pessimism after a kicking. Very understandable, but time to shake that off and see the direction this is headed not just on the chart but fundamentally too.
Yes like Simple says, this has a lot of support already, we can see that even after a brutal shake and no real news for weeks on end, the share price recovered. We're in a clear upward channel now. We had the Half Yearly which didn't deliver the response traders wanted and those guys are pulling out until they catch wind of the next RNS.
There is good sticky money here though, if there wasn't this would have popped yesterday as sentiment was poor.
If anyone's worried about this drifting all the way down to the low 200s or whatever again, it's not something you need to stress over. You'd need a large selloff for that to happen again. You can have dips and small shakes by the MM, those are common across all AIM stocks weekly, but the direction looks good with future figures to show growth and new news to give this momentum.
Remember why this has got a kicking - NCYT haven't told the market anything interesting in nearly two months.
Some vague news about R&D? Some new products which we'd already expected, and no news on margins or sales? Something about a push into the US?
It's all vague and washy. You can't get away with that while the market thinks Covid is a bubble. We're lucky this is mid 200s and up trending. Everything else is dying a slow death day on day. We're recovering because we have actual cash coming in and growth. Good luck to anyone else in anything else, it's all tanking, check your charts.
A few solid updates and this will gain momentum and confidence, and we know it's all coming. We can see it happening in the background, the video production, the documents found online about sales and contracts, mobile developments, and new product testing etc. It's all there, just the market needs informed and hopefully that's soon.
@Matt
How many Covid stocks made even half that in the same period?
Actually, while you're at it. How many companies in any industry make 20+ million a month in sales in their first few months of selling any product?
A lot of people neglected to read further yesterday. There were comments today asking why there wasn't more cash in the bank. The RNS states they've spent the cash on "investment in R&D to support continued growth, including a number of new products and innovations to be launched in the near future. "
And they'll update us on those shortly. Definitely interesting things happening in the background. My instinct is that there's a big play happening here in the background while we're squabbling amongst ourselves.
I just hope an update comes sooner rather than later, and by that I mean I'd like to see something by end of week.
That's been far overstated. The UK government has done nothing of the sort and neither has France.
The issue with foreign takeovers during the crisis, was that you could have had a good French or British PPE or vaccine company make a breakthrough product and quickly a US company could have swooped in and taken all the vaccine supplies for their home turf.
Complete travesty and political nightmare, and Trump was already pushing that agenda.
Anyway, the UK govt. have given themselves a little more power so that if a company wants to do a takeover of a key vaccine or PPE manufacturer for example, then the govt. gets a first look. If govt. says it's okay then it will proceed through the usual channels.
Absolutely nothing legislated at all in the UK.
In France all they did was increase their powers of scrutiny so they can now review bids of 10% shares, whereas previously the threshold was 25% before they could have a look and a say at it.
They just don't want Trump stealing all the vaccine supplies. That's all it was. Was a lot of scaremongering back in late April about Trump trying to buy up important European medical supplies.
@cringsing "Remind me, why would anybody spend $1bn on a CoVid testing company, knowing a vaccine plausibly is 9-15 months away?"
Because the Homeland Security Research's best analysts did a deep dive on the various Covid markets and reckon the PCR testing market alone will be worth over $20 billion:
Homeland Security Research
https://homelandsecurityresearch.com/reports/cvoid-19-pandemic-mitigation-products-market/
BRC
https://www.researchandmarkets.com/reports/5017373/polymerase-chain-reaction-pcr-and-real-time?utm_source=dynamic&utm_medium=CI&utm_code=czw7hj&utm_campaign=1385824+-+Polymerase+Chain+Reaction+(PCR)+and+Real-Time+PCR+Testing+Market+Worth+%2422.4+Billion+in+2020%2c+due+to+the+Surge+in+Number+of+Tests+Being+Conducted+for+the+Diagnosis+of+COVID-19&utm_exec=joca220cid
You can see the Covid bubble pop in June in the Covid index:
****************************/index/vox-covid-19/
The lowest point is around the week the UK was announcing lockdown easing, but it's recovering since then.
There will be more losers than winners unfortunately. I just can't see too many people who bought in around June on covid stocks getting out on most of them without a heavy loss. There's likely only two or three that will really be able to recover their share price. Clearly I think NCYT is one hence why I'm here. Nothing else is making cash like it.
That said, there's a chance that come August and September we will see sentiment move back into these companies as they slowly release new contracts and sales figures and show growth. News of vaccines failing hurdles and constant outbreaks and second waves could help even the worst performers claw back their share price.
@JohnHenry "And dont bet against the MKT you will loose."
Like Warren Buffet whose strategy is to find stocks the market has undervalued.
Maybe you should give him a call and offer some tips!
:)
It's totally that, basically the market is impressed with NCYT's sales, it's just uncertain that sales will continue for an length of time.
That confidence will increase as covid outbreaks continue and NCYT releases news on how it's investing the windfall into new areas.
No-one wants to see cash in the bank. That's a nail in the coffin. Essentially it would mean you found a warchest and didn't know what to do with it. We need to see 30mil a month coming in and the cash re-invested into these new respiratory areas they've tipped us off on.
Edit: meant to say higher highs and higher lows. Anyway chart there shows it clearly if you can see past the million indicators.
Look, can see the channel we're in at the moment, it's a strong upwards trend, just no-one likes the down days. But highs are definitely getting higher and lows much, much lower.
https://ibb.co/S75wLJS
Remember, only about 15% to 300p here. That's nothing but a touch of confidence signalled to the market. Yesterday was a bit disappointing, but that's over with. It's all growth from here, greater sales and new products and developments month on month.
I wish NCYT would put out a few good RNS close together though, to give this a bit of a catalyst though. Market likes something to get excited about.
Actually been higher highs and lower lows since 15th June. We have the same chart.
We'll start seeing monthly sales updates again now the Half Yearly is out of the way, so early August for the next one, which show the greatest monthly sales figure yet, and by far larger than any other Covid stock out there.
Before then though we've got news on:
The US Market
New Product Contracts
Primer Design Global Marketing Launch (production by
Possible New Saliva Test
Mobile Testing Update
Tons of stuff around the corner, and more no doubt. What else for July / early August?
Well it's hard to knock NCYT now that the Annual and Half Yearly results are coming out.
We all knew this was a horse race when we were jumping into Covid stocks months back and now we're seeing the winners take the lead. Ultimately it's the accountants that have the final word and unfortunately it's not looking great for late starters.
NCYT's next RNS's for global markets and new products will be destructive for other Covid stocks as growth projections will be crazy for the next 12 months. Not to mention we haven't got July sales yet. That cash will come here, it'll be a safer haven for growth.
Big scare story in the UK today about the second wave so should lend a bit of support to Covid stocks. The Times article won't hurt either. Generally it's looking positive for NCYT. Projected growth and the market will be there for some time yet.
Anyway, fingers crossed!